Literature DB >> 667492

Hypotension produced by intravenous apomorphine in the anaesthetized dog is not centrally mediated.

M G Bogaert, W A Buylaert, J L Willems.   

Abstract

1 Intravenous administration of apomorphine (1.25 to 20 microgram/kg) in the anaesthetized dog produced a dose-dependent decrease in blood pressure which was antagonized by haloperidol but not influenced by propranolol or atropine. 2 Intracarotid administration of apomorphine produced a systemic hypotension which was significantly smaller than that seen with intravenous injection. 3 Doses of apomorphine that caused a decrease in blood pressure on intravenous injection, had no effect on blood pressure or caused retching accompanied by an increase in blood pressure on intravertebral or intracisternal administration. The animals showed a marked hypotension on intravertebral or intracisternal injection of clonidine. 4 From these results it is concluded that the hypotension seen with intravenous apomorphine cannot be explained by a central site of action.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 667492      PMCID: PMC1668087          DOI: 10.1111/j.1476-5381.1978.tb07801.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  10 in total

1.  Dopamine-like renal and mesenteric vasodilation caused by apomorphine 6-propylnorapomorphine and 2-amino-6, 7-dihydroxy-1,2,3,4-tetrahydronaphthalene.

Authors:  H J Crumly; R M Pinder; W B Hinshaw; L I Goldberg
Journal:  Nature       Date:  1976-02-19       Impact factor: 49.962

2.  Dopamine receptors in the femoral vascular bed of the dog as mediators of a vasodilator and sympathoinhibitory effect.

Authors:  M Laubie; H Schmitt; E Falq
Journal:  Eur J Pharmacol       Date:  1977-04-07       Impact factor: 4.432

Review 3.  Cardiovascular and renal actions of dopamine: potential clinical applications.

Authors:  L I Goldberg
Journal:  Pharmacol Rev       Date:  1972-03       Impact factor: 25.468

4.  Dopamine-induced inhibition of synaptic transmission in lumbar paravertebral ganglia of the dog.

Authors:  J L Willems
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

5.  L-dopa hypotension in dogs: evidence for mediation through 5-HT release.

Authors:  M J Antonaccio; R D Robson
Journal:  Arch Int Pharmacodyn Ther       Date:  1974-11

6.  Hypotensive effect of apomorphine in anesthetized cats.

Authors:  A Barnett; J W Fiore
Journal:  Eur J Pharmacol       Date:  1971-04       Impact factor: 4.432

7.  Dopamine-induced neurogenic vasodilatation in isolated perfused muscle preparation of the dog.

Authors:  J L Willems; M G Bogaert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

8.  Vasodilatation produced by apomorphine in the hindleg of the dog.

Authors:  W A Buylaert; J L Willems; M G Bogaert
Journal:  J Pharmacol Exp Ther       Date:  1977-06       Impact factor: 4.030

9.  Inhibition of the sympathetic nervous system by 5,6-dihydroxy-2-dimethylamino tetralin (M-7), apomorphine and dopamine.

Authors:  J P Long; S Heintz; J G Cannon; J Kim
Journal:  J Pharmacol Exp Ther       Date:  1975-02       Impact factor: 4.030

10.  Hyperprolactinaemia and antihypertensive effect of bromocriptine in essential hypertension. Identification of abnormal central dopamine control.

Authors:  K O Stumpe; R Kolloch; M Higuchi; F Krück; H Vetter
Journal:  Lancet       Date:  1977-07-30       Impact factor: 79.321

  10 in total
  4 in total

1.  Subcutaneous apomorphine increases regional cerebral blood flow in parkinsonian patients via peripheral mechanisms.

Authors:  U Sabatini; O Rascol; P Celsis; G Houin; A Rascol; J P Marc-Vergnes; J L Montastruc
Journal:  Br J Clin Pharmacol       Date:  1991-08       Impact factor: 4.335

2.  Inhibitory effects of apomorphine and pergolide on neurogenic vasoconstriction in the hindquarters of the rat.

Authors:  A G Dupont; R A Lefebvre; M G Bogaert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-04       Impact factor: 3.000

3.  Characterization of withdrawal syndrome of morphine-dependent rats prepared by intermittent infusion technique.

Authors:  Y Koga; T Inukai
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

Review 4.  Side effects of a dopamine agonist therapy for Parkinson's disease: a mini-review of clinical pharmacology.

Authors:  Josip Anđelo Borovac
Journal:  Yale J Biol Med       Date:  2016-03-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.